People with chronic graft-versus-host disease (chronic GVHD)
struggle physically and emotionally. REZUROCK was shown to help

REZUROCK was evaluated in 2 clinical studies that included a total of 186 people.

More than

7OUT OF10

people in the ROCKstar study found symptom relief

Many people found symptom relief within 4 to 8 weeks.

Everyone responds to medicine differently. Some people may take longer to respond, especially if their organs are damaged by scarring.

People saw improvement across multiple organs

pink circular icon of an arm with a skin rash

Skin

pink circular icon of an eye

Eyes

pink circular icon of an open mouth with teeth

Mouth

pink circular icon of a bent knee joint

Joints and
muscles

pink circular icon of the intestinal tract

GI tract

pink circular icon of the liver

Liver

pink circular icon of the lungs

Lungs

pink circular icon of the esophagus

Esophagus

People saw improvement across multiple organs

pink circular icon of an arm with a skin rash

Skin

pink circular icon of an eye

Eyes

pink circular icon of the intestinal tract

GI tract

pink circular icon of the liver

Liver

pink circular icon of an open mouth with teeth

Mouth

pink circular icon of a bent knee joint

Joints and
muscles

pink circular icon of the lungs

Lungs

pink circular icon of the esophagus

Esophagus

In some people, REZUROCK also reduced the need
for steroids and other immunosuppressants.

People who found symptom relief with REZUROCK were at different stages of their treatment journey and

  • Tried different medicines, besides steroids, for chronic GVHD that failed to control their symptoms
  • Had either mild, moderate or severe chronic GVHD
  • Had 1 or more organs affected by chronic GVHD

Immunosuppressants (ih-myoo-no-suh-preh-sents), such as steroids, suppress (reduce the strength of) your immune system.

What are the side effects of REZUROCK?

Why most people were able to keep taking REZUROCK

pink circular icon of a round and an oblong pill

In clinical studies, side effects with REZUROCK were similar to those expected in people receiving steroids and other medicines for chronic GVHD.

pink circular icon of a white arrow rotating clockwise in a circle

There were NO NEW CASES of cytomegalovirus (CMV) infection and only 1 case of recurring CMV infection.

CMV is a common serious infection that can happen in people who have had a blood stem cell transplant.

pink circular icon with a white arrow pointing down

There was a low rate of serious cytopenia (site-oh-pee-nia), a condition that causes a lower-than-normal number of certain blood cells.

The most common side effects reported by people taking REZUROCK in clinical studies were

  • Infections
  • Tiredness or weakness
  • Nausea
  • Diarrhea
  • Shortness of breath
  • Cough
  • Swelling
  • Bleeding
  • Stomach (abdominal) pain
  • Muscle or bone pain
  • Headache
  • High blood pressure

Be sure to tell your health care provider about any side effects you have. They may be able to help you find ways to manage them.

GI, gastrointestinal; GVHD, graft-versus-host disease.

USE

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD) after you have received at least 2 prior treatments (systemic therapy) and they did not work. It is not known if REZUROCK is safe and effective in children less than 12 years old.

IMPORTANT SIDE EFFECT INFORMATION

Before taking REZUROCK, tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney or liver problems.
  • are pregnant or plan to become pregnant. REZUROCK can harm your unborn baby. If you are able to become pregnant, your healthcare provider will do a pregnancy test before starting treatment with REZUROCK. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with REZUROCK.
  • - Females who can become pregnant should use effective birth control during treatment with REZUROCK and for at least 1 week after the last dose.
  • - Males with female partners who can become pregnant should use effective birth control during treatment with REZUROCK and for at least 1 week after the last dose.
  • are breastfeeding or plan to breastfeed. It is not known if REZUROCK passes into breast milk. Do not breastfeed during treatment with REZUROCK and for at least 1 week after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. REZUROCK may affect the way other medicines work, and other medicines may affect the way REZUROCK works.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take REZUROCK?

  • Take REZUROCK exactly as your healthcare provider tells you to take it.
  • Do not change your dose or stop taking REZUROCK without first talking to your healthcare provider.
  • Take REZUROCK 1 time a day with a meal.
  • Take REZUROCK at about the same time each day.
  • Swallow REZUROCK tablets whole with a glass of water.
  • Do not cut, crush, or chew REZUROCK tablets.
  • Your healthcare provider will do blood tests to check your liver at least 1 time a month during treatment with REZUROCK.
  • If you miss a dose of REZUROCK, take it as soon as you remember on the same day. Take your next dose of REZUROCK at your regular time on the next day. Do not take extra doses of REZUROCK to make up for a missed dose.
  • If you take too much REZUROCK, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of REZUROCK?

The most common side effects of REZUROCK include:

  • infections
  • tiredness or weakness
  • nausea
  • diarrhea
  • shortness of breath
  • cough
  • swelling
  • bleeding
  • stomach (abdominal) pain
  • muscle or bone pain
  • headache
  • high blood pressure

Your healthcare provider may change your dose of REZUROCK, temporarily stop, or permanently stop treatment with REZUROCK if you have certain side effects.

REZUROCK may affect fertility in males and females. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of REZUROCK. Call your doctor for medical advice about side effects.

Please see full Prescribing Information.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. You may also contact Kadmon Pharmaceuticals, LLC, at 1-877-377-7862 to report side effects.

pink circular icon with plus sign

Use

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD)

IMPORTANT SIDE EFFECT INFORMATION Before taking REZUROCK, tell your healthcare provider about all of your medical conditions, including if you: pink circular icon with plus sign

Use & Important side effect information

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children